Role of mucosal mast cells in Helicobacter pylori infection

Journal of Gastroenterology

Volumn 37, Issue 1, 2002, Pages 70-72

  Otaka, Michiro ^a   Watanabe, Sumio ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 8;

ANIMAL CELL; CHRONIC GASTRITIS; CONTROLLED STUDY; EDITORIAL; ENTEROCHROMAFFIN CELL; HELICOBACTER INFECTION; HISTAMINE RELEASE; MAST CELL; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PEPTIC ULCER; PRIORITY JOURNAL; RISK FACTOR; STOMACH ACID SECRETION; STOMACH EROSION; STOMACH MUCOSA INJURY; STOMACH ULCER;

ANIMALS; CELLS, CULTURED; CYTOKINES; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE RELEASE; HUMANS; MAST CELLS;

EID: 0036172274     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s535-002-8137-4     Document Type: Editorial

References (25)

1. Helicobacter pylori infection and the development of gastric cancer
2. New insights into the role of cytokines in asthma
3. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751
4. Development and sequels of intestinal inflammation in nematode-infected rats: Role of mast cells and capsaicin-sensitive afferents
5. Blockade of either alpha-4 or beta-7 integrins selectively inhibits intestinal mast cell hyperplasia and worm expulsion in response to Nippostrongylus brasiliensis infection
6. Schistosoma mansoni infection causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine
7. Role of mast cells as a trigger of inflammation in Helicobacter pylori infection
8. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung
9. Mast cell involvement in gastritis with or without Helicobacter pylori infection
10. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell-and platelet-activating factor receptor-dependent pathway in rats
11. Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase
12. Pretreatment with mild irritant enhances prostaglandin E2 release from isolated canine gastric mucosal mast cells
13. Isolation of histamine-containing cells from canine fundic mucosa
14. Effects of interleukin-8 and Helicobacter pylori on histamine release from isolated canine gastric mucosal mast cells
15. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
16. Immunobiological activities of Helicobacter pylori porins
17. Mast cell chemotactic activity of RANTES
18. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils
19. Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients-evaluation of 24-h pH monitoring
20. Involvement of gastrin in gastric secretory and protective actions of N-alpha-methyl histamine
21. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy
22. Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole
23. Helicobacter pylori infection prevents erosive-reflux oesophagitis by decreasing gastric acid secretion
24. Helocobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
25. Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis